Chemotherapy

Anticancer chemotherapy is the administration of cytotoxic or cytostatic drugs to treat cancer.

Chemotherapy is by nature systemic, so it is used in cases where it is no longer so localized. The later the diagnosis is made (often for objective reasons), the more likely it is that cancer will spread beyond the primary site, so chemotherapy becomes necessary. Chemotherapy is indicated whenever the disease is considered to be extensive from the outset, and whenever surgery or radiotherapy is considered not to have completely sterilized the patient. It is often given in various combinations with all other treatments. Especially with oncothermia, synergy is observed, in order to increase the therapeutic gain. Sometimes, when chemotherapy is gradually developed, oncotherapy again gives hope for the return of chemotherapy. In advanced cases with multiple and diffuse metastases, chemotherapy is given in parallel with full body hyperthermia, which acts as both an adjuvant and an immunostimulant.

In recent years, chemotherapy has been used in selected cases, targeting only the tumor area. This is made possible by the application of arterial catheterization. For example, if the tumor is located in the liver, it is possible to catheterize the hepatic artery, and through it to administer chemotherapy, very close to the tumor, either by simple infusion or by so-called chemoembolization. It is a significant breakthrough in classical systemic chemotherapy.

Today, for the most part, combinations of more than one drug are used, simultaneously or in a fixed sequence of time, to achieve synergy. These are the well-known protocols. Protocols are scientifically substantiated therapies, with great statistical but much less practical value. This is the reason for the small effect they have on reducing cancer mortality, as we analyzed in another section. For example, Protocol A is compared with another Protocol B, which is applied to two similar groups of patients. If A offered his team a therapeutic advantage over B, then he is statistically better. In other words, if the B protocol achieved a cure at 5%, and the A protocol achieved a cure at 10%, it means that the A protocol offers a 100% increase in successful output. This seems like an astonishing achievement in theory. In practice, however, the real effect of the difference in effectiveness is very small, in relation to the enormous costs and the decline in quality of life caused to patients by applying both A and B, especially if one considers the absolute numbers.

Of course, drugs have many differences, and the intolerances, side effects and toxicities that are observed vary considerably. And, of course, significant progress is being made. At Cancer Therapy we are very sensitive and skeptical about chemotherapy, so we provide it based on the indications of effectiveness that result from individualized diagnostic tests (cell cultures of circulating cancer cells of this particular patient). In other words, we follow a methodology similar to the susceptibility test of microbial cultures. This is a great advantage of the treatments we offer. We also combine chemotherapy with oncothermia, or when needed, with full-body hyperthermia, to help the patient gain chemotherapy.

To treat the side effects of chemotherapy, such as nausea and vomiting, we use conventional drugs as well as cannabinoids. These herbal remedies are now legal for medical use, and they control the side effects as well as the cancer anorexia.

Cannabinoids are drugs legal for medical use, and they have excellent control over the side effects of chemotherapy, as well as cancer anorexia and cachexia.

Another serious side effect of chemotherapy is bone marrow aplasia. It is treated with factors that stimulate the bone marrow to produce blood cell lines. This aplasia, in its extreme form, becomes a desolation of the marrow.Desertification means that all of its stem cells have died, in an effort to prolong the use of drugs that will sterilize the cancer. This very serious condition is treated quite successfully with a bone marrow transplant, preferably with an autologous graft.